Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. The disease recurrent rate is relatively high resulted in poor 5-year survival in advanced HCC. | IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness metastasis and drug resistance via regulating met Src signaling pathway